Ehrenstein Boris, Schwarz Timo, Fleck Martin, Günther Florian
Klinik für Rheumatologie/Klinische Immunologie, Asklepios Klinikum Bad Abbach, Kaiser-Karl-V.-Allee 3, 93077, Bad Abbach, Deutschland.
Orthopädische Klinik für die Universität Regensburg, Asklepios Klinikum Bad Abbach, Bad Abbach, Deutschland.
Z Rheumatol. 2021 May;80(4):348-352. doi: 10.1007/s00393-021-00990-9. Epub 2021 Apr 6.
To reduce the risk of SARS-CoV‑2 infections, special hygiene measures apply to all German healthcare facilities. Despite the national goals and the existence of comprehensive testing for the detection of asymptomatic or presymptomatic SARS-CoV‑2 infections in all inpatients, no equivalent screening with rapid antigen tests has yet been established for outpatients. The acceptance of such screening with associated waiting times and inconvenience for affected patients has been insufficiently investigated.
We performed a self-administered anonymous survey of outpatients on their willingness to comply with the hygiene requirements, to undergo rapid antigen screening tests for asymptomatic/presymptomatic infections with SARS-CoV‑2 and to receive SARS-CoV‑2 vaccination.
From 7 to 15 December 2020, 534 patients completed the survey, 195 (37%) from rheumatism and 339 (63%) from orthopedic outpatient clinics. Most patients accepted wearing a mouth-nose covering (475/534, 89%) and attending clinics without an accompanying person to prevent overcrowding of the waiting areas (450/534, 84%). A large majority (428/534 patients, 80%) accepted mandatory screening with rapid antigen tests and the associated waiting time of 15-20 min outside the hospital (449/534, 84%). More than half of the responders reported willingness to receive a SARS-CoV‑2 vaccination (yes, immediately 137 (26%), yes, maybe 142 (27%) patients), with significantly (p < 0.05) more male, more rheumatic and more patients older than 60 years indicating a wish to be vaccinated.
The results revealed a high acceptance of COVID-19 hygiene measures including initial screening by rapid antigen testing.
为降低感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的风险，德国所有医疗保健机构都实施了特殊的卫生措施。尽管有国家目标，且对所有住院患者进行了全面检测以发现无症状或症状前的SARS-CoV-2感染，但尚未为门诊患者建立同等的快速抗原检测筛查。对于此类筛查以及给受影响患者带来的等待时间和不便，其接受度尚未得到充分调查。
我们对门诊患者进行了一项自我管理的匿名调查，了解他们遵守卫生要求、接受SARS-CoV-2无症状/症状前感染快速抗原筛查检测以及接种SARS-CoV-2疫苗的意愿。
2020年12月7日至15日，534名患者完成了调查，其中195名（37%）来自风湿病门诊，339名（63%）来自骨科门诊。大多数患者接受佩戴口鼻罩（475/534，89%）以及独自前往诊所就诊以防止候诊区过度拥挤（450/534，84%）。绝大多数（428/534名患者，80%）接受了快速抗原检测的强制筛查以及在医院外15至20分钟的相关等待时间（449/534，84%）。超过一半的受访者表示愿意接种SARS-CoV-2疫苗（愿意，立即接种137名（26%），愿意，可能接种142名（27%）患者），男性、患有风湿病以及60岁以上的患者表示希望接种疫苗的比例显著更高（p<0.05）。
结果显示，包括通过快速抗原检测进行初步筛查在内的新冠病毒卫生措施的接受度很高。
